Ralph Moss: CANCER DRUG TRIALS: QUITTING WHILE YOU'RE AHEAD - PART I I

[Guest guest]

Ralph W. Moss, Ph.D. Weekly CancerDecisions.com

Newsletter #338 04/27/08

 

THE MOSS REPORTS - CANCER DECISIONS NEWSLETTER

 

CANCER DRUG TRIALS: QUITTING WHILE YOU'RE AHEAD - PART I I

 

When clinical trials of new cancer drugs are halted early because of a

positive response trend in those receiving the new drug, the early

stoppage is generally heralded as an example of progress, a welcome

glimmer of hope. But there is also a potential downside to stopping

clinical trials early which is often overlooked. Last week we began a

two-part discussion of the implications of early trial stoppage. This

week we conclude that discussion, with references.

http://www.cancerdecisions.com/042708.html